Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Mangoceuticals (MGRX) Invested Capital (2023 - 2025)

Historic Invested Capital for Mangoceuticals (MGRX) over the last 3 years, with Q3 2025 value amounting to $15.7 million.

  • Mangoceuticals' Invested Capital rose 1747.61% to $15.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $15.7 million, marking a year-over-year increase of 1747.61%. This contributed to the annual value of $13.9 million for FY2024, which is 170007.19% up from last year.
  • Mangoceuticals' Invested Capital amounted to $15.7 million in Q3 2025, which was up 1747.61% from $19.2 million recorded in Q2 2025.
  • Mangoceuticals' Invested Capital's 5-year high stood at $20.3 million during Q1 2025, with a 5-year trough of -$958468.0 in Q1 2024.
  • Its 3-year average for Invested Capital is $10.1 million, with a median of $13.6 million in 2024.
  • The largest annual percentage gain for Mangoceuticals' Invested Capital in the last 5 years was 221293.86% (2025), contrasted with its biggest fall of 1747.61% (2025).
  • Over the past 3 years, Mangoceuticals' Invested Capital (Quarter) stood at $774754.0 in 2023, then surged by 1700.07% to $13.9 million in 2024, then grew by 12.79% to $15.7 million in 2025.
  • Its Invested Capital stands at $15.7 million for Q3 2025, versus $19.2 million for Q2 2025 and $20.3 million for Q1 2025.